Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

CHU de Nantes

Home Clinical Trial Sponsors and OrganizationsCHU de Nantes

CHU de Nantes

ACTIVE

Francewww.chu-nantes.frPrivate

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

35

34 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

18

51.4%

Trial Status Distribution

Active, not recruiting

34

97.1%

Recruiting

1

2.9%

Clinical Trials

Trials sponsored by this organization (35)

/A

Active, not recruiting

Jun 2021210 participants

/A

May 2021106 participants

REmimazolam infusion in the context of Hypnotic Shortage in the Critical care Unit during the pandemic of COVID-19. The non-randomized, non-controlled, pilot, open, mono-centric REHSCU study.

Active, not recruiting

Oct 202030 participants

/A

Active, not recruiting

Aug 2020370 participants

Comparison of pharmacokinetic (PK) levels before and after conversion from tacrolimus to extended-release tacrolimus (ENVARSUS®) in diabetic transplant recipients

Active, not recruiting

Jan 202025 participants

Optimization of skin preparation to reduce Cutibacterium acnes colonization in superficial and deep samples during prosthetic shoulder surgery in male patients

Active, not recruiting

Jul 2019110 participants

MEchanisms of resitance in EGFR mutated nonpretreated advanced Lung cancer Receiving OSimErtib

Active, not recruiting

Nov 201866 participants

/A

Active, not recruiting

Dec 2017120 participants

Page 1 of 5

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials35
Approvals
News

Back to Organizations